TQB3015
/ Sino Biopharm
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
December 29, 2023
A Clinical Trial of TQB3015 Tablets in Patients With Advanced Malignant Cancer
(clinicaltrials.gov)
- P1 | N=0 | Withdrawn | Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Not yet recruiting ➔ Withdrawn
Metastases • Trial withdrawal • Oncology
December 13, 2023
A Clinical Trial of TQB3015 Tablets in Patients With Advanced Malignant Cancer
(clinicaltrials.gov)
- P1 | N=73 | Not yet recruiting | Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
New P1 trial • Oncology
1 to 2
Of
2
Go to page
1